The Santa Rosa-based electronics test and measurement company reported fiscal third-quarter sales grew 11%, but tariffs, ...

CSL is laying off up to 15% of its workforce as the Australian pharma looks to cut R&D costs and spin out its vaccine ...

There's more than one way to account for Research and Development (R&D). A business using the accrual method of accounting will treat R&D costs as expenses. A business contracted to undertake R&D ...

Each of these studies indicate the challenges of estimating R&D costs attributable to one product, and the difficulty, at the level of one company, of accounting for failures.

Rare diseases are becoming the focus of more and more biomedical research. And the cost of developing medicines to treat them takes center stage in the discussion. A new article in JAMA concludes that ...

This is how for-profit, publicly traded pharma companies work in the U.S. They are focused on recouping R&D costs and offering a nice payout to investors. Other countries use a different model.

If R&D costs got us better drugs to make us healthier, they might be worth it; but we’re largely getting a proliferation of harmful side effects for little benefit.

Biotech R&D costs are outpacing revenues, but funding is still strong, report says By Meghana Keshavan Reprints Alex Hogan/STAT ...

I cover news on drugs and R&D in the pharma industry via my Follow Author Apr 21, 2022, 07:33am EDTApr 22, 2022, 09:14am EDT ...